86 related articles for article (PubMed ID: 31049958)
1. CD markers variations in chronic lymphocytic leukemia: New insights into prognosis.
Vosoughi T; Bagheri M; Hosseinzadeh M; Ehsanpour A; Davari N; Saki N
J Cell Physiol; 2019 Nov; 234(11):19420-19439. PubMed ID: 31049958
[TBL] [Abstract][Full Text] [Related]
2. Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.
Palacios F; Yan XJ; Ferrer G; Chen SS; Vergani S; Yang X; Gardner J; Barrientos JC; Rock P; Burack R; Kolitz JE; Allen SL; Kharas MG; Abdel-Wahab O; Rai KR; Chiorazzi N
Leukemia; 2021 Apr; 35(4):1037-1052. PubMed ID: 33504942
[TBL] [Abstract][Full Text] [Related]
3. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia.
Baldoni S; Del Papa B; Dorillo E; Aureli P; De Falco F; Rompietti C; Sorcini D; Varasano E; Cecchini D; Zei T; Di Tommaso A; Rosati E; Alexe G; Roti G; Stegmaier K; Di Ianni M; Falzetti F; Sportoletti P
Int J Cancer; 2018 Aug; 143(4):958-970. PubMed ID: 29508386
[TBL] [Abstract][Full Text] [Related]
4. The molecular map of CLL and Richter's syndrome.
Sud A; Parry EM; Wu CJ
Semin Hematol; 2024 Apr; 61(2):73-82. PubMed ID: 38368146
[TBL] [Abstract][Full Text] [Related]
5. Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates.
Mazzarello AN; Gugiatti E; Cossu V; Bertola N; Bagnara D; Carta S; Ravera S; Salvetti C; Ibatici A; Ghiotto F; Colombo M; Cutrona G; Marini C; Sambuceti G; Fais F; Bruno S
Cancer Immunol Immunother; 2024 Jan; 73(2):27. PubMed ID: 38280019
[TBL] [Abstract][Full Text] [Related]
6. Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.
Ronchetti D; Mosca L; Cutrona G; Tuana G; Gentile M; Fabris S; Agnelli L; Ciceri G; Matis S; Massucco C; Colombo M; Reverberi D; Recchia AG; Bossio S; Negrini M; Tassone P; Morabito F; Ferrarini M; Neri A
BMC Med Genomics; 2013 Sep; 6():27. PubMed ID: 24004562
[TBL] [Abstract][Full Text] [Related]
7. Siglec-6 as a therapeutic target for cell migration and adhesion in chronic lymphocytic leukemia.
Nunes J; Tafesse R; Mao C; Purcell M; Mo X; Zhang L; Long M; Cyr MG; Rader C; Muthusamy N
Nat Commun; 2024 Jun; 15(1):5180. PubMed ID: 38890323
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between leukemic and immune cells at the tumor microenvironment in chronic lymphocytic leukemia: An update review.
Taghiloo S; Asgarian-Omran H
Eur J Haematol; 2024 Jul; 113(1):4-15. PubMed ID: 38698678
[TBL] [Abstract][Full Text] [Related]
9. SOLUBLE CD150 ISOFORM LEVEL IN PLASMA OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.
Gordiienko I; Shcherbina V; Shlapatska L
Exp Oncol; 2024 Feb; 45(4):457-462. PubMed ID: 38328844
[TBL] [Abstract][Full Text] [Related]
10. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.
Chng WJ; Schop RF; Price-Troska T; Ghobrial I; Kay N; Jelinek DF; Gertz MA; Dispenzieri A; Lacy M; Kyle RA; Greipp PR; Tschumper RC; Fonseca R; Bergsagel PL
Blood; 2006 Oct; 108(8):2755-63. PubMed ID: 16804116
[TBL] [Abstract][Full Text] [Related]
11. Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia.
Guièze R; Wu CJ
Blood; 2015 Jul; 126(4):445-53. PubMed ID: 26065654
[TBL] [Abstract][Full Text] [Related]
12. Expression signature of human endogenous retroviruses in chronic lymphocytic leukemia.
Ferlita A; Nigita G; Tsyba L; Palamarchuk A; Alaimo S; Pulvirenti A; Balatti V; Rassenti L; Tsichlis PN; Kipps T; Pekarsky Y; Croce CM
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2307593120. PubMed ID: 37871223
[TBL] [Abstract][Full Text] [Related]
13. High mitochondrial DNA stability in B-cell chronic lymphocytic leukemia.
Cerezo M; Bandelt HJ; Martín-Guerrero I; Ardanaz M; Vega A; Carracedo A; García-Orad A; Salas A
PLoS One; 2009 Nov; 4(11):e7902. PubMed ID: 19924307
[TBL] [Abstract][Full Text] [Related]
14. Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemia.
Su X; Lucas DM; Zhang L; Xu H; Zabrouskov V; Davis ME; Knapp AR; Young DC; Payne PR; Parthun MR; Marcucci G; Grever MR; Byrd JC; Freitas MA
Proteomics; 2009 Mar; 9(5):1197-206. PubMed ID: 19253275
[TBL] [Abstract][Full Text] [Related]
15. Nanowire-mediated delivery enables functional interrogation of primary immune cells: application to the analysis of chronic lymphocytic leukemia.
Shalek AK; Gaublomme JT; Wang L; Yosef N; Chevrier N; Andersen MS; Robinson JT; Pochet N; Neuberg D; Gertner RS; Amit I; Brown JR; Hacohen N; Regev A; Wu CJ; Park H
Nano Lett; 2012 Dec; 12(12):6498-504. PubMed ID: 23190424
[TBL] [Abstract][Full Text] [Related]
16. The end of the beginning: application of single-cell sequencing to chronic lymphocytic leukemia.
Nagler A; Wu CJ
Blood; 2023 Jan; 141(4):369-379. PubMed ID: 36095842
[TBL] [Abstract][Full Text] [Related]
17. Chromatin network markers of leukemia.
Malod-Dognin N; Pancaldi V; Valencia A; Pržulj N
Bioinformatics; 2020 Jul; 36(Suppl_1):i455-i463. PubMed ID: 32657405
[TBL] [Abstract][Full Text] [Related]
18. Binucleated and cloverleaf-shaped nucleus in lymphocytes in CLL.
Barros Pinto MP; Cabeçadas J
Blood; 2024 Feb; 143(9):833. PubMed ID: 38421814
[No Abstract] [Full Text] [Related]
19. Clinical Flow-Cytometric Testing in Chronic Lymphocytic Leukemia.
Salem DA; Stetler-Stevenson M
Methods Mol Biol; 2019; 2032():311-321. PubMed ID: 31522426
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
Hallek M
Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
